Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.005 | 0.001 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.005 | 0.001 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.005 | 0.005 |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | 0.3297 | 1 | 1 |
Giardia lamblia | Kinase, CMGC GSK | 0.0441 | 0.1177 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0074 | 0.0042 | 0.0042 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0441 | 0.1177 | 0.5 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0441 | 0.1177 | 1 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | 0.3297 | 1 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.005 | 0.005 |
Entamoeba histolytica | protein kinase, putative | 0.0441 | 0.1177 | 0.5 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | 0.3297 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0074 | 0.0042 | 0.0002 |
Brugia malayi | RNA binding protein | 0.0076 | 0.005 | 0.005 |
Giardia lamblia | Kinase, CMGC GSK | 0.0441 | 0.1177 | 1 |
Echinococcus granulosus | protein kinase shaggy | 0.0441 | 0.1177 | 0.1141 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0441 | 0.1177 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0041 | 0.5 |
Loa Loa (eye worm) | CDC7 protein kinase | 0.0074 | 0.0042 | 0.0042 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0441 | 0.1177 | 0.1177 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0441 | 0.1177 | 0.1141 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.005 | 0.005 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.005 | 0.001 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.0041 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.005 | 0.001 |
Brugia malayi | intracellular kinase | 0.0441 | 0.1177 | 0.1177 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.005 | 0.001 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0441 | 0.1177 | 0.1177 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0441 | 0.1177 | 0.5 |
Echinococcus multilocularis | protein kinase shaggy | 0.0441 | 0.1177 | 0.1141 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0441 | 0.1177 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0041 | 0.5 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0441 | 0.1177 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0041 | 0.5 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0441 | 0.1177 | 1 |
Onchocerca volvulus | 0.0441 | 0.1177 | 1 | |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0441 | 0.1177 | 0.1141 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.005 | 0.005 |
Echinococcus granulosus | CDC7 cell division cycle 7 | 0.0074 | 0.0042 | 0.0002 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0441 | 0.1177 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.005 | 0.005 |
Echinococcus multilocularis | CDC7 cell division cycle 7 | 0.0074 | 0.0042 | 0.0002 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0441 | 0.1177 | 0.1141 |
Trypanosoma brucei | protein kinase, putative | 0.0441 | 0.1177 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.005 | 0.001 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0441 | 0.1177 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.005 | 0.001 |
Schistosoma mansoni | serine/threonine protein kinase | 0.3297 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (binding) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.